Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 400 participants.

Also called NCT04331769

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 400 participants (planned count) (from the registry)
Sponsor
Ancora Heart, Inc. (from the registry)
Registry
  • NCT NCT04331769
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Belarus, Belgium, Czechia, France, Germany, Greece, Italy, Netherlands, Serbia (from the registry)
Registry status
  • Suspended (from the registry)

Technical summary

Registry record NCT04331769. Randomized; no masking; primary purpose treatment. Start 2020-12-21 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study
Condition
Dilated Cardiomyopathy
Intervention (Device)
AccuCinch Ventricular Restoration System
Intervention (Drug)
Guideline-Directed Medical Therapy
Lead sponsor
Ancora Heart, Inc. (class: industry)

Record details

Record id
cardio:ct-nct04331769
Content hash
f495c5f591d877ec1a96c310078efd45522509b732379d4b0dd35a55c3c23530